Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis

Indian Journal of Medical Research

Volumn 123, Issue 2, 2006, Pages 125-130

  Gupta, Pushpa ^a   Jadaun, G P S ^a   Das, Ram ^a   Gupta, U D ^a   Srivastava, Kiran ^a   Chauhan, Aradhana ^a   Sharma, V D ^a   Chauhan, D S ^a   Katoch, V M ^a  

^a NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

Author keywords

Ethambutol; Isoniazid; Minimum inhibitory concentration; Multi drug resistant; Rifampicin; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHAMBUTOL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RESEARCH SUPPORT, NON-U.S. GOV'T;

EID: 33645470252     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. JAMA 1999; 282: 677-86.
2. Pathania V, Almeida J, Kochi A. TB patients and private for profit health care providers in India Geneva: World Health Organization; 1997; WHO/TB/97.223.
3. Cohn DL, Bustreo F, Raviglione MC. Drug resistant tuberculosis: Review of the world wide situation and the WHO/IUATLD global surveillance project. Clin Infect Dis 1997; 24: S121-30.
4. Trivedi SS, Desai SG. Primary anti-tuberculosis drug resistance and acquired rifampicin resistance in Gujarat, India. Tubercle 1988; 69: 37-42.
5. Chandrasekaran S, Chauhan MM, Rajalakshmi R, Chaudhuri K, Mahadev B. Initial drug resistance to anti-tuberculosis drugs in patients attending an urban district tuberculosis centre. Indian J Tuberc 1990; 37: 215-6.
6. Chandrasekaran S, Jagota P, Chaudhuri K. Initial drug resistance to anti-tuberculosis drugs in urban and rural district tuberculosis programme. Indian J Tuberc 1992; 39 171-5.
7. Gupta PR, Singhal B, Sharma TN, Gupta RB. Prevalence of initial drug resistance in tuberculosis patients attending a chest hospital. Indian J Med Res 1993; 97: 102-3.
8. Paramasivan CN, Bhaskaran K, Venkataraman P, Chandrasekaran V, Narayanan PR. Surveillance of drug resistance in tuberculosis in the state of Tamil Nadu. Indian J Tuberc 2000; 47: 27-33.
9. Jena J, Panda BN, Nema SK, Ohri VC, Pahwa RS. Drug resistance pattern of Mycobacterium tuberculosis in a chest disease hospital of armed forces. Lung India 1995; 13: 56-9.
10. Rosha D, Kataria VK. Impact of initial drug resistance pattern on the maintenance phase of short course chemotherapy with reference to the emergence of multi drug resistance. Indian J Tuberc 2001; 48: 205-7.
11. Varaiya A, Gogate A. Drug resistance to the first line of antitubercular regimen (a preliminary report). Indian J Public Health 1998; 42: 126-30.
12. Sachdeva R, Gadre DV, Talwar V. Characterisation and drug susceptibility patterns of extrapulmonary mycobacterial isolates. Indian J Med Res 2002; 115: 102-7.
13. Mendoza MT, Gonzaga AJ, Roa C, Velmonte MA, Jorge M, Montoya JC, et al. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippines general hospital, Manila, Philippines. Int J Tuberc Lung Dis 1997; 1: 59-63.
14. Aziz A, Siddiqi SH, Aziz K, Ishaq M. Drug resistance of Mycobacterium tuberculosis isolated from treated patients in Pakistan. Tubercle 1989; 70: 45-51.
15. Narang P, Mendiratta DK, Kanathe J. Characterization of Mycobacterium tuberculosis variants in Wardha District. Indian J Tuberc 1997; 44: 21-6.
16. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in the tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
17. Gangadharam PRJ, Pratt PF, Perumal VK, Iseman MD. The effects of exposure time, drug concentration, and temperature on the activity of ethambutol versus Mycobacterium tuberculosis. Am Rev Respir Dis 1990; 141: 1478-82.
18. Madison B, Robinson-Dunn B, George I, Gross W, Lipman H, Metchock B, et al. Multicenter evaluation of ethambutol susceptibility testing of Mycobacterium tuberculosis by agar proportion and radiometric methods. J Clin Microbiol 2002; 40: 3976-9.
19. Vestal AL. In: Procedures for isolation and identification of mycobacteria. US Department of Health, Education and Welfare. Publication no. CDC-77-8230, CDC Atlanta, Georgia; 1977 p. 65-98.
20. Anti-tuberculosis drug resistance in the world. The WHO/IUTALD global project on anti-tuberculosis drug resistance surveillance. WHO/TB/ 97.229. Geneva, Switzerland; 1997 p. 37.
21. Paramasivan CN, Chandrasekaran V, Santha T, Sudarsanam NM, Prabhakar R. Bacteriological investigations for short course chemotherapy under the tuberculosis programme in two districts of India. Tuberc Lung Dis 1993; 74: 23-7.
22. Manual on isolation, identification and sensitivity testing of Mycobacterium tuberculosis. Bangalore: National Tuberculosis Institute; 1998 p. 24-9.
23. Chenevier P, Massias L, Gueyrard D, Farinotti R. Determination of ethambutol in plasma by high-performance liquid chromatography after pre-column derivatization. J Chromatogr 1998; 708: 310-5.
24. Lee CS, Gambertoglio JG, Brater DC, Benet LZ. Kinetics of oral ethambutol in the normal subject. Clin Pharmacol Ther 1977; 22: 615-21.
25. Inderlied CB, Salfinger M. Antimicrobial agents and susceptibility test. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Mycobacteria - Manual of clinical microbiology. Washington, DC; American Society for Microbiology; 1995 p. 1385-404.
26. Heifets LB. Qualitative and quantitative drug susceptibility tests in mycobacteriology. Am Rev Respir Dis 1988; 137: 1217-22.